Atossa Therapeutics
ATOS
#10748
Rank
S$25.53 M
Marketcap
S$2.56
Share price
1.28%
Change (1 day)
149.46%
Change (1 year)

Market capitalization of Atossa Therapeutics (ATOS)

Market cap: S$25.53 Million

As of November 2026 Atossa Therapeutics has a market cap of S$25.53 Million. This makes Atossa Therapeutics the world's 10748th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Atossa Therapeutics from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026S$25.53 M-76.63%
2025S$0.10 B-34.87%
2024S$0.16 B15.2%
2023S$0.14 B62.33%
2022S$89.71 M-67.25%
2021S$0.27 B358.33%
2020S$59.75 M209.2%
2019S$19.32 M137.23%
2018S$8.14 M-27.22%
2017S$11.19 M44.81%
2016S$7.73 M-47.71%
2015S$14.78 M-68.15%
2014S$46.41 M-14.99%
2013S$54.59 M-11.39%
2012S$61.61 M

End of Day market cap according to different sources

On Nov 15th, 2026 the market cap of Atossa Therapeutics was reported to be:

S$25.21 Million
by Nasdaq info icon info icon
S$25.21 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$880.90 B 3,449,799.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
S$37.13 B 145,337.58%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$38.85 B 152,085.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
S$3.64 B 14,155.81%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
S$2.59 B 10,076.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
S$47.16 M 84.70%๐Ÿ‡บ๐Ÿ‡ธ USA